SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-028061
Filing Date
2023-08-14
Accepted
2023-08-14 08:20:47
Documents
50
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1095799
2 ex31-1.htm EX-31.1 10919
3 ex31-2.htm EX-31.2 10797
4 ex32-1.htm EX-32.1 5929
5 ex32-2.htm EX-32.2 5915
  Complete submission text file 0001493152-23-028061.txt   4533902

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sonn-20230630.xsd EX-101.SCH 33476
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sonn-20230630_cal.xml EX-101.CAL 36990
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sonn-20230630_def.xml EX-101.DEF 146341
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sonn-20230630_lab.xml EX-101.LAB 261312
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sonn-20230630_pre.xml EX-101.PRE 210431
44 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 665520
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Filer) CIK: 0001106838 (see all company filings)

IRS No.: 522102141 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35570 | Film No.: 231166474
SIC: 2834 Pharmaceutical Preparations